|
⚲
|
| Keyboard |
| Lotz Christopher L
✚
|
|
|---|---|
| CIK # | 0001812553 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001812553] | |
| 4 | [0001812553] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ritter Pharmaceuticals Inc | |
| Lotz Christopher L |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2022-07-11 | Grant | 100,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2021-04-16 | Buy | 2,700 | $1.86 | 5,022 |
|
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
|
2020-06-06 | Grant | 600,000 | $0.00 | |
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 22,142 | ||
|
Ritter Pharmaceuticals Inc QLGN
Common Stock
|
2020-05-22 | Other | 9,841 | ||
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 3,543 | ||
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 22,142 | ||
|
Ritter Pharmaceuticals Inc QLGN
Warrant (Right to Buy) · derivative
|
2020-05-22 | Other | 29,847 |